Effects of reference pricing and tender contracts in Germany

Timm Volmer & Hanna Fieke
Introduction: The therapeutic reference price system (RP) in Germany is regarded as a successful mechanism to reduce pharmaceutical spending. However, price directed measures such as the so-called payer contracts (pharmaceutical tender contracts (TC)) interact with the reference price mechanism. The[for full text, please go to the a.m. URL]